March 13, 2009 – HIMSS said today that with less than a month before HIMSS 2009, total conference registration parallels the record-breaking registration figures during this same time frame for last year’s show.

March 13, 2009 - A comprehensive analysis published this week in The Lancet from the ABSORB clinical trial demonstrated that Abbott’s bioabsorbable drug eluting stent (DES), currently in development, successfully treated coronary artery disease and was absorbed into the walls of treated arteries within two years.

March 13, 2009 - BridgePoint Medical Inc. completed the first human clinical case in the U.S. using its CrossBoss CTO Catheter and Stingray CTO Re-Entry System.

March 13, 2009 – HemCon Medical Technologies is displaying at SIR 2009 its new flexible HemCon Patch designed for use for external, temporary control of bleeding during interventional and diagnostic cardiac catheterization, interventional radiology, electrophysiology and dialysis access procedures.

March 13, 2009 -Medical device pioneer Stentys said today it extended its self-expanding and disconnectable technology platform to include a second major indication - acute myocardial infarction (AMI).

Two patients were successfully treated during AMI procedures last week by Drs. S. Verheye in Antwerp, Belgium and K. E. Hauptmann in Trier, Germany.

March 12, 2009 – Today, FDAnews and the Neocure Group revealed details today of the upcoming Medical Device Reimbursement Strategies Workshops, which will be held in Boston (April 30-May 1) and Minneapolis (August 24-25).

March 12, 2009 - CeloNova BioSciences Inc. said yesterday physicians performing a live stent implantation during the annual scientific meeting of the Sociedad Venezolana de Cardiologia Intervencionista (SOVECI), March 13-14, elected to use the CATANIA Coronary Stent System with NanoThin Polyzene-F to demonstrate the benefits of this innovative new stent technology.

March 11, 2009 - Siemens Healthcare will showcase advanced imaging applications like the new syngo iFlow and a new medical-grade large display, which provides a 56-inch active, full-color widescreen for procedures at SIR booth 400 in San Diego March 7 – 12, 2009.

March 10, 2009 - W. L. Gore & Associates today said the first clinical use of the GORE Flow Reversal System for neuroprotection during carotid artery stenting (CAS) was performed by Daniel McCormick, M.D. and Sheldon Goldberg, M.D., interventional cardiologists at Hahnemann University Hospital, Philadelphia.


March 11, 2009 - The St. Jude Medical Genesis neurostimulation system designed for managing chronic angina pectoris, or chronic angina, has received European CE approval.
The Genesis system helps to control angina pain by sending mild pulses of electricity from a device implanted in the torso via thin insulated wires called leads to nerves located along the spinal cord.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now